Gregg Nyberg

Chief Technology Officer • Landmark Bio

Gregg Nyberg, Ph.D., brings more than 20 years’ biopharmaceutical industry experience to his new role at Landmark Bio. Most recently, he was associate vice president at Merck, where he led the company’s biologics process development and clinical manufacturing organizations. He also spent nearly 15 years in positions of increasing responsibility at Amgen including key leadership roles in process development and cell sciences and technology.

Dr. Nyberg earned a Ph.D. in chemical engineering from the Massachusetts Institute of Technology and a B.S. in chemical engineering and petroleum refining from the Colorado School of Mines.

Also Speaking

Fran Gullo

Scientific Director, Gift of Life Center for Cell and Gene Therapy • Gift of Life Biologics

Roel Gordijn

Chief Commercial Officer • Polyplus

Konstantina Katcheves

Senior Vice President Business Development • Bristol Myers Squibb

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.